Spiro5,6-dihydro-4H-2,3,5,10b-tetraaza-benz o(e)azulenes
Details for Australian Patent Application No. 2009315754 (hide)
International Classifications
Event Publications
28 April 2011 PCT application entered the National Phase
PCT publication WO2010/054961 Priority application(s): WO2010/054961
12 May 2011 Corrigenda
PCT applications that have entered the National Phase - Name Index Under the name F. Hoffmann-La Roche AG, Application No. 2009315754, under INID (54) correct the title to Spiro5,6-dihydro-4H-2,3,5,10b-tetraaza-benzo[e]azulenes
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2009315761-Quinazoline derivatives as NK3 receptor antagonists
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser
